In the multivariate analysis, women with ER-positive tumours were more likely to die than women with ER-negative tumours (HR 2.08, 95% CI 0.99–4.36, p = 0.05), and this was of borderline significance.
← all excerpts
Oestrogen receptor status and survival in women with BRCA2-associated breast cancer.
1
—
—